Sarah C J Jorgensen, Chan Kulatunga-Moruzi, Karine Khatchadourian
{"title":"Limitations of Randomized Controlled Trials for Detecting and Characterizing Harms: Methodological Reflections on the PATHWAYS Trial.","authors":"Sarah C J Jorgensen, Chan Kulatunga-Moruzi, Karine Khatchadourian","doi":"10.1080/0092623X.2026.2752383","DOIUrl":null,"url":null,"abstract":"<p><p>PATHWAYS is the first randomized controlled trial (RCT) to evaluate puberty suppression in youths with gender incongruence. This article examines whether methodological features of PATHWAYS allow a comprehensive safety assessment. Although RCTs are considered the gold standard for establishing effectiveness, their capacity to detect and characterize harm is limited. We challenge assumptions that evidence certainty frameworks developed for effectiveness generalize to harm. We distinguish the role of randomization in estimating intended benefits versus unintended harm, for which confounding by indication is typically not the primary threat to validity. We argue key design elements including modest sample size, short follow-up, restrictive eligibility criteria, intention-to-treat analysis, and uninformative Bayesian priors, are likely to limit the trial's capacity to detect and characterize harms, especially those that are rare, delayed, developmentally contingent, or unexpected. We conclude that a comprehensive safety assessment requires integration of multiple complementary evidence sources, and should precede and inform judgements about clinical equipoise, risk-benefit balance, and PATHWAYS trial design.</p>","PeriodicalId":17171,"journal":{"name":"Journal of Sex & Marital Therapy","volume":" ","pages":"1-11"},"PeriodicalIF":2.2000,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sex & Marital Therapy","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/0092623X.2026.2752383","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FAMILY STUDIES","Score":null,"Total":0}
引用次数: 0
Abstract
PATHWAYS is the first randomized controlled trial (RCT) to evaluate puberty suppression in youths with gender incongruence. This article examines whether methodological features of PATHWAYS allow a comprehensive safety assessment. Although RCTs are considered the gold standard for establishing effectiveness, their capacity to detect and characterize harm is limited. We challenge assumptions that evidence certainty frameworks developed for effectiveness generalize to harm. We distinguish the role of randomization in estimating intended benefits versus unintended harm, for which confounding by indication is typically not the primary threat to validity. We argue key design elements including modest sample size, short follow-up, restrictive eligibility criteria, intention-to-treat analysis, and uninformative Bayesian priors, are likely to limit the trial's capacity to detect and characterize harms, especially those that are rare, delayed, developmentally contingent, or unexpected. We conclude that a comprehensive safety assessment requires integration of multiple complementary evidence sources, and should precede and inform judgements about clinical equipoise, risk-benefit balance, and PATHWAYS trial design.
期刊介绍:
The Journal of Sex and Marital Therapy is one of the top independent journals in the field. Under the prestigious leadership of R. Taylor Seagraves, M.D. - one of the world" foremost experts in sex and marital therapy -- JSMT is an active and contemporary forum reflecting the most viable developments emanating from the U.S. and abroad. JSMT continues to break new ground with innovative research and clinical writing, and the editor is committed to showcasing the most far-reaching traditional and contemporary thinking from all sources. You will read about therapeutic techniques, outcome, special clinical and medical problems, and the theoretical parameters of sexual functioning, and marital relationships.